According to the Lancet, having cancer and VTE at the same time increases mortality risk.

Published Date: 16 Oct 2023

Deep venous thrombosis and pulmonary embolism are both parts of venous thromboembolism, a condition that primarily affects the elderly. cancer is connected to it.

Read Full News

Latest News

Transforming Perioperative MIBC Care in Community Practice: Navigating Emerging Data, Guideline Changes, and Adverse Event Management Protocols

Transforming Perioperative MIBC Care in Community Practice: Navigating Emerging Data, Guideline Changes, and Adverse Event Management Protocols

Doctors Remain Trusted Sources for Cancer Info in Post-Pandemic Era

Not surprisingly, trust in government health agencies for cancer info has dipped

Groundbreaking Pancreatic Cancer Drug Shows Promise in Lung Cancer

Response rates with daraxonrasib ranged from 31% to 37% in previously treated RAS-mutant NSCLC

Blood Cancer's First New Drug in 29 Years; AI for Mammography? Phase III Myeloma Win

News, features, and commentary about cancer-related issues

More Evidence Ties Microplastics to Lung Cancer

Observational study shows greater microplastic burden in patients with lung malignancy

Nationwide Epinephrine Recall; FBI's Fauci Probe; Bruce Campbell's Cancer

Health news and commentary gathered by MedPage Today staff

Todays Updates

Diagnosis of Mass Confined to the Kidney: Is It RCC or TCC?

Ureteroscopy and histopathology should be considered as routine preoperative assessments

BRAF Inhibition in Pediatric Ameloblastoma of the Jaw

Targeted therapy in 3 boys allowed for conservative surgery to restore jaw to predisease state

Todays Updates

Diagnosis of Mass Confined to the Kidney: Is It RCC or TCC?

Ureteroscopy and histopathology should be considered as routine preoperative assessments

BRAF Inhibition in Pediatric Ameloblastoma of the Jaw

Targeted therapy in 3 boys allowed for conservative surgery to restore jaw to predisease state

Latest News

Transforming Perioperative MIBC Care in Community Practice: Navigating Emerging Data, Guideline Changes, and Adverse Event Management Protocols

Not surprisingly, trust in government health agencies for cancer info has dipped

Response rates with daraxonrasib ranged from 31% to 37% in previously treated RAS-mutant NSCLC

News, features, and commentary about cancer-related issues

Observational study shows greater microplastic burden in patients with lung malignancy

Health news and commentary gathered by MedPage Today staff

News All Time

Novel Drug Cuts Risk for Death by 44% in Squamous Lung Cancer Trial

If approved, immunotherapy gotistobart could offer a chemo-free option in second-line setting

Drug Combo's Response Rates Top 90% in Small Cell Lung Cancer Trial

Bispecific antibody and ADC together impress in early study

ROS1-Targeting Lung Cancer Drug Yields 90% Response Rate

Early efficacy among the highest seen in lung cancer, expert says

Woman Develops Tiny Blood Spots on Her Body After COVID Shot

Case highlights need for quick diagnosis and management of rare disorder

Two Survival Wins in NSCLC With Bispecific Seeking Worldwide Status

Ivonescimab topped pembrolizumab alone or paired with chemotherapy in separate trials

Patient's Colonoscopy Refusal Highlights Value of CRC Screening

Man with a first-degree relative with CRC initially only agreed to stool-based testing

RFK Jr. Eyes Wireless, RF Radiation; Cancer by the Month; AI for Cancer Symptoms

News, features, and commentary about cancer-related issues

FDA Staff Find No Major Concerns With Galleri Multicancer Early Detection Test

— Comments were noncommittal in agency document released ahead of advisors' meeting

Definium's LSD-based Anxiety, Depression Drug Scores Another Trial Win

Definium Therapeutics said on Monday its LSD-based treatment reduced symptoms of generalized anxiety disorder ⁠in a second successful late-stage study for the...

Liberalized Cannabis Policies May Increase Substance Use

In a global review, legalization was associated with increased cannabis use and related emergency department visits, with potential decreases in the use of alcohol and tobacco.

UK Lawmakers Reject Bid to Legalise Assisted Dying

British lawmakers rejected on Friday a proposal to legalise assisted dying for terminally ill people, dealing a major setback to campaigners and bringing the latest effort...

‘Modest’ Differences in OAT Should Not Obscure Benefits

Methadone may be linked to a lower risk for death than buprenorphine-naloxone in the short term, but after an overdose, either opioid agonist therapy is better than none.

EU Flags Shortage Of Schizophrenia Drug Injections Due to Manufacturing Issues

(This Aug 27 story has been republished, with no changes to text.)

Less Seniors Taking Inappropriate Cognitive Meds

Older adults with cognitive disorders who use inappropriate medications linked to adverse cognitive effects are more likely to have poor mental health-related quality of life.

US Health Department Seeks Public Feedback on Vaccine Guidelines After Trump Order

The U.S. health department said on Friday it was seeking public feedback on federal vaccine recommendations, including how they ⁠are categorized and communicated, after...

Alzheimer's Blood Test Gets FDA Clearance

The U.S. Food and Drug Administration has cleared Roche and partner Eli Lilly's blood ⁠test to help identify signs of Alzheimer's disease in people aged 55 and older with...

Recommended News For You

Could the Prostate Cancer Story of Francis Collins Dissuade Men from Active Surveillance?

In myelofibrosis, combinations of rufolitinib reduce spleen volume.

Distinct results for patients with positive and negative pancreatic cancer who are treated with systemic therapy, chemotherapy, and radiation.

According to the Lancet, having cancer and VTE at the same time increases mortality risk.

Genetics and therapy type determine second cancer risk after childhood treatment, study finds

In Advanced Myxoid Liposarcoma, Is Trabectedin Winning?

US Health Department Seeks Public Feedback on Vaccine Guidelines After Trump Order

Recommended Articles For You

Methemoglobinemia in OR & ICU: Pathophysiology, Detection, and Management Review 

Engineering the Future of Oncology with CAR- Natural Killer Cell Design & Therapeutics 

The Link Between Being Overweight and Cancer 

Optimizing Chemotherapy Dosing: From Phase 1 Dose Escalation to Modification 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

In a clinical trial, "3D mammography" nearly reduces the incidence of breast cancer between two screening exams.

2.

In prostate cancer survivorship, sleep disturbances are underappreciated.

3.

Rural colon cancer patients face higher risks, but minimally invasive surgery could narrow gap

4.

Study finds 81% of cancer cures touted by TikTok videos are fake

5.

Defibrotide Prophylaxis May Reduce SOS Risk After HSCT

1.

Antibody-Drug Conjugates and the Dawn of Targeted Cancer Therapy in 2025

2.

Understanding Hemosiderosis: Causes, Symptoms, and Treatment Options

3.

Decoding the Padua Score to Prevent Blood Clots in High-Risk Patients

4.

Preventing Functional Iron Deficiency in High-Risk Populations

5.

Red Blood Cell Aging and Clinical Implications

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management

2.

Efficient Management of First line ALK-rearranged NSCLC - Part V

3.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VI

4.

Navigating the Complexities of Ph Negative ALL - Part XVI

5.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot